Physician profile
Theodore E Workman
NPI 1316970031
$13,017.12
in general payments reported to CMS, 2019-2025
25 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514 · 2020: $1,263 · 2021: $2,543 · 2022: $2,591 · 2023: $349 · 2024: $3,552 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,419 · Travel and Lodging: $1,510 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,418.66 |
| Travel and Lodging | $1,509.66 |
| Education | $177.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,139.28 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $2,058.99 | 2021-2022 | |
| Curonix LLC | $1,464.97 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $1,315.58 | 2019-2023 | Proclaim |
| Vertos Medical, INC. | $1,268.28 | 2021-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $896.21 | 2022-2025 | Sprint Pns System |
| Nevro Corp. | $888.78 | 2019-2024 | Senza |
| Tersera Therapeutics LLC | $177.00 | 2024 | Prialt |
| Painteq LLC | $147.80 | 2024 | Painteq |
| Relievant Medsystems, INC. | $127.85 | 2022 | |
| Medtronic USA, INC. | $115.50 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $55.72 | 2020-2024 | Xtampza |
| Stimwave Technologies Incorporated | $51.00 | 2021 | |
| Depuy Synthes Sales INC. | $45.90 | 2022-2024 | Monovisc, Orthovisc |
| Abbvie INC. | $39.93 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $33.67 | 2022 | |
| Medtronic, INC. | $32.72 | 2024 | Synchromedii, V-Loc 180 |
| Biodelivery Sciences International, INC. | $30.50 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $28.86 | 2021 | |
| Almatica Pharma LLC | $20.87 | 2021 | |
| Allergan, INC. | $20.55 | 2020 | |
| Pfizer INC. | $15.90 | 2019 | |
| Amgen INC. | $15.26 | 2021 | |
| Avanos Medical | $13.70 | 2025 | Coolief Cooled Radiofrequency |
| Lilly USA, LLC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.